St. Jude Children's Research Hospital will host the Scientific Symposium on Bone Marrow Failure and Myelodysplastic Syndromes: From Discovery to Future Strategies on October 25–27, 2026, in partnership with the North American Pediatric Aplastic Anemia Consortium (NAPAAC). NAPAAC is a research consortium established in 2011 to advance research and therapies in pediatric bone marrow failure and myelodysplastic syndromes.
About the symposium
Bone marrow failure (BMF) disorders and myelodysplastic syndromes (MDS) represent over 20 disease entities with at least 150 causative genes. Despite rapid progress in genetic diagnostics, developing targeted therapies and deploying effective surveillance remain a critical challenge.
This symposium brings together >60 academic centers who are members of the NAPAAC consortium. In addition, global leaders in bone marrow failure from Europe, Asia, South America, and Australia will share discoveries and clinical insights on genetics, transplantation, gene therapy, predisposition syndromes, and emerging treatment strategies.
Program highlights
- Sunday, October 25 (from 3pm):
Opening session on international collaboration and patient advocacy. - Monday, October 26 (8am – 6pm) and Tuesday, October 27 (8am – 1pm):
Scientific sessions on hematopoiesis, genomics, disease mechanisms, and emerging therapies including novel transplant strategies and genome engineering. Poster session to showcase basic, translational and clinical research within NAPAAC. - Networking and collaboration:
This interactive event provides opportunities to network with peers, engage in strategic discussions on emerging treatment approaches, and connect across the global community. Dedicated time will be offered for NAPAAC working groups to discuss progress and define future priorities.
Confirmed international speakers
- Lucy Fox, MBBS, DMedSc – Melbourne, Australia
- Biju George, MBBS, MD, DM – Vellore, India
- Carmem Bonfim, MD, PhD –Curitiba, Brazil
- Hideki Muramatsu, MD, PhD – Nagoya, Japan
- Yang Wan, MD – Tianjin, China
- Shaoyan Hu, MD, PhD – Suzhou, China
- Lucy A. Godley, MD, PhD – Chicago, US
- Wojciech Młynarski, MD, PhD – Łódź, Poland
- Charlotte M. Niemeyer, MD – Freiburg, Germany (Chair, EWOG-MDS)
- Brigitte Strahm, MD – Freiburg, Germany (Chair: EWOG-SAA)
- Susana Navarro, PhD – Madrid, Spain
- Anita Frisanco Oliveira, MD – Barretos, Brazil
- Riccardo Masetti, MD, PhD – Bologna, Italy
-
NAPAAC Scientific Symposium welcomes abstract submissions from all trainees and established investigators working on bone marrow failure and myelodysplastic syndromes, and related fields. You must be registered for the symposium as an in-person attendee to submit an abstract.
Abstract submission deadline: August 14, 2026, at 6:00 p.m. Central Time.
Notification of Decision: August 26, 2026.Top scoring abstracts will be selected for oral presentations. Limited number of awards to cover the hotel accommodation will be granted to the authors of the highest-scoring abstracts, as determined following the review by the scientific committee.
-
CME/continuing medical education credits are offered. The event is open to hematologists, oncologists, hematopathologists, transplant specialists, advanced practice providers, scientists and trainees with an interest in advancing care and treatment of patients with bone marrow failure and myelodysplastic syndromes.
-
Registration Type (in person) Early Bird
by August 14, 2026Late Registration
August 14 – October 10, 2026St. Jude Employee Free Free Invited Speaker Free Free NAPAAC Center - Trainee (student, postdoc, clinical fellow, resident) Free $200 NAPAAC Center - Other (including PI, physician, APP, genetic counselor) $70 $250 St. Jude Affiliate $70 $250 External: Academic $400 $500 External: All Others, Including Industry $800 $1,000 Virtual participation options will be added in August.
Included in registration:
- St. Jude Employee: meals during conference only (no dinner or transportation included).
- All others: meals during conference, dinners, and transportation to/from hotel.